156 related articles for article (PubMed ID: 4769481)
41. [Are hypoglycemic sulfonamides dangerous?].
Aubertin MJ
Bord Med; 1972 Nov; 5(17):2287-90. PubMed ID: 4571486
[No Abstract] [Full Text] [Related]
42. Controversy over study of diabetes drugs continues for nearly a decade.
Kolata GB
Science; 1979 Mar; 203(4384):986-90. PubMed ID: 370980
[No Abstract] [Full Text] [Related]
43. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
Cornfield J
JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
[No Abstract] [Full Text] [Related]
44. Tolbutamide: another view.
Nahum LH
Conn Med; 1971 Apr; 35(4):272-3. PubMed ID: 5108037
[No Abstract] [Full Text] [Related]
45. Are antidiabetic drugs dangerous?
Br Med J; 1970 Nov; 4(5733):444-5. PubMed ID: 5481216
[No Abstract] [Full Text] [Related]
46. The Tolbutamide evidence.
Lancet; 1971 Jan; 1(7691):171-2. PubMed ID: 4102190
[No Abstract] [Full Text] [Related]
47. Fatal vascular complications in diabetic patients treated by diet, sulfonylureas and insulin. A retrospective study.
Fidel J; Nelken L
Isr J Med Sci; 1974 Jul; 10(7):702-6. PubMed ID: 4852026
[No Abstract] [Full Text] [Related]
48. Editorials: Statistical problems in clinical trials: the UGDP study revisited.
Schor SS
Am J Med; 1973 Dec; 55(6):727-32. PubMed ID: 4584989
[No Abstract] [Full Text] [Related]
49. A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide.
Diabetes; 1976 Dec; 25(12):1129-53. PubMed ID: 992232
[No Abstract] [Full Text] [Related]
50. [Letter: Heart death and oral antidiabetics].
de Nobel E; van 't Laar A
Ned Tijdschr Geneeskd; 1975 Nov; 119(44):1732-3. PubMed ID: 1214881
[No Abstract] [Full Text] [Related]
51. [Use of tolbutamide in diabetes and pregnancy].
Villanueva Gasca A; María García L; López Villegas J; Núñez E
Ginecol Obstet Mex; 1975 Aug; 38(226):133-7. PubMed ID: 1175987
[No Abstract] [Full Text] [Related]
52. [Causes of death in diabetes mellitus].
Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
[No Abstract] [Full Text] [Related]
53. Letter: The UGDP scandal and cover-up.
Moss JM
JAMA; 1975 May; 232(8):806-8. PubMed ID: 1173182
[No Abstract] [Full Text] [Related]
54. Oral hypoglycemic agents.
Breidahl HD
Med J Aust; 1973 Apr; 1(16):815-6. PubMed ID: 4707804
[No Abstract] [Full Text] [Related]
55. Oral treatment of diabetes mellitus.
Chhetri MK
J Indian Med Assoc; 1968 May; 50(10):486-8. PubMed ID: 4883853
[No Abstract] [Full Text] [Related]
56. The clinical evaluation of an oral antidiabetic drug.
Müller R
Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
[No Abstract] [Full Text] [Related]
57. Oral hypoglycaemic agents and cardiovascular complications of diabetes. Effect of long-term administration of tolbutamide and phenformin on the metabolism of glycosaminoglycans in normal rats.
Prasannan K; Kurup PA
Atherosclerosis; 1973; 18(3):459-67. PubMed ID: 4270849
[No Abstract] [Full Text] [Related]
58. Therapeutics: recent suggestions for the treatment of hypothyroidism and diabetes mellitus.
Block MB
Ariz Med; 1975 Apr; 32(4):344-6. PubMed ID: 1119957
[No Abstract] [Full Text] [Related]
59. Medical guest editorial: The oral diabetic drug controversy.
Am Fam Physician; 1975 Dec; 12(6):73-4. PubMed ID: 1202930
[No Abstract] [Full Text] [Related]
60. The crux of the UGDP. Spurious results and biologically inappropriate data analysis.
Kilo C; Miller JP; Williamson JR
Diabetologia; 1980 Mar; 18(3):179-85. PubMed ID: 6989693
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
